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Abstract
Background: The impact of signal-dependent transcription factors, such as glucocorticoid receptor and nuclear
factor kappa-b, on the three-dimensional organization of chromatin remains a topic of discussion. The possible
scenarios range from remodeling of higher order chromatin architecture by activated transcription factors to
recruitment of activated transcription factors to pre-established long-range interactions.
Results: Using circular chromosome conformation capture coupled with next generation sequencing and
high-resolution chromatin interaction analysis by paired-end tag sequencing of P300, we observed agonist-induced
changes in long-range chromatin interactions, and uncovered interconnected enhancer–enhancer hubs spanning up
to one megabase. The vast majority of activated glucocorticoid receptor and nuclear factor kappa-b appeared to join
pre-existing P300 enhancer hubs without affecting the chromatin conformation. In contrast, binding of the activated
transcription factors to loci with their consensus response elements led to the increased formation of an active
epigenetic state of enhancers and a significant increase in long-range interactions within pre-existing enhancer
networks. De novo enhancers or ligand-responsive enhancer hubs preferentially interacted with ligand-induced genes.
Conclusions: We demonstrate that, at a subset of genomic loci, ligand-mediated induction leads to active enhancer
formation and an increase in long-range interactions, facilitating efficient regulation of target genes. Therefore, our data
suggest an active role of signal-dependent transcription factors in chromatin and long-range interaction remodeling.
Keywords: ChIA-PET, Chromosome conformation capture, Enhancer, GR, Long-range interaction, NFκB, P300,
Transcription regulation
Background
Mechanisms of transcriptional response mediated by
signal-dependent transcription factors (inducible TFs)
are not well understood at the level of chromatin top-
ology. Recent genome-wide studies have revealed that
the majority of TF binding sites (up to 90 %) are distal
to promoters and located in intragenic and intergenic re-
gions [1–9]. These studies collectively revealed cell-type-
specific constellations of distal regulatory regions that
change during differentiation and development in a
highly ordered fashion, whereby some distal regulatory
regions are being set up de novo and others are decom-
missioned. This implies that at least some lineage-
specific and/or signal-dependent TFs effectively open
the chromatin structure and prepare the chromatin for
subsequent binding of other TFs. A simplistic model of
how such plasticity can be achieved is that long-range
interactions among and between enhancers and pro-
moters are dynamically established or disrupted. Many
recent studies have purported an active or “instructive”
role of inducible TFs in mediating long-range chromatin
contacts for efficient regulation of target genes [10–14].
The orchestrated long-range interaction changes have
also been reported in embryonic stem cells (ESC) and
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ESC-derived lineages [15] on a topological domain
(TAD) level. In contrast, other studies suggest a static or
“permissive” model in which inducible TFs passively join
pre-existing interaction networks of regulatory elements
without affecting the organization of long-range interac-
tions [14, 16, 17]. The HoxD locus serves as an example
of pre-formed long-range interactions [18]. Interestingly,
in another report focusing on the HoxD locus, the
authors directly compared the interaction profiles ob-
tained by chromosome conformation capture (3C)-based
methods and fluorescent in situ hybridization. The au-
thors conclude that interactions identified by 3C-based
methods at such high resolution do not always represent
true proximal ligations, but may be a consequence of in-
direct cross-linking [19]. Discrepancies between studies
on inducible TF-mediated long-range chromatin con-
tacts may be due to differences in resolution and meth-
odology or to the use of asynchronous cells.
Glucocorticoid receptor (GR) is a ligand inducible TF
that belongs to the nuclear receptor superfamily [20].
Hormone binding dissociates the GR-containing cyto-
plasmic complex; GR then translocates to the nucleus
where it binds to chromatin to regulate target gene ac-
tivity. Nuclear factor kappa-b (NFκB) is a heterodimeric
TF that regulates various biological processes such as
cell growth, development, and the inflammatory re-
sponse. In response to inflammatory stimuli such as the
pro-inflammatory cytokine tumor necrosis factor alpha
(TNFα), NFκB dissociates from an inhibitory cytoplas-
mic complex, translocates to the nucleus, and subse-
quently regulates its target genes [21–25]. Co-activated
GR and NFκB share a large proportion of genomic regu-
latory elements and co-regulate many genes in a mutual
antagonistic or synergistic manner [7, 26–29]. The ma-
jority of GR and p65 (a major NFκB subunit) binding
events occur at genomic loci that exhibit pre-existing
enhancer signatures. In this scenario, TFs other than GR
and NFκB have established and maintain an open chro-
matin conformation, facilitating binding or recruitment
of GR and p65 to their binding sites [30–32]. At a mi-
nority of GR and p65 binding sites (~10 %), the activated
TFs establish de novo enhancer-like loci [5, 33, 34].
To gain insight in how GR and NFκB regulate their
target gene repertoire from distal binding sites (DBSs),
we mapped the chromatin interactions before and after
GR and NFκB activation by generating high-resolution
chromatin interaction profiles using the chromatin inter-
action analysis by paired-end tag sequencing (ChIA-
PET) method [35, 36]. We used antibodies against
enhancer-associated P300 and against RNA polymerase
II (POLII). P300 is a co-factor shared by GR and NFκB
and its genomic occupancy in general is considered a
hallmark of active enhancers [37–40]. We scrutinized
the local chromatin interaction networks at genomic loci
that are de novo established and compared them to
those of pre-existing loci. We extended our analysis
using high-resolution circular chromosome conform-
ation capture (4C) technology on a subset of genomic
viewpoints harboring de novo programmed regulatory
elements. Collectively, our comprehensive analyses re-
veal a role of signal-dependent TF-induced dynamic
changes in chromatin regulatory networks and its im-
pact on gene regulation.
Results
P300 is recruited to latent distal binding sites by ligand
activated GR and/or NFκB
To gain insight into the impact of GR activation on the
chromatin state and three-dimensional (3D) organization,
we first performed chromatin immunoprecipitation
followed by deep sequencing (ChIP-seq) for GR, P300,
epigenetic marks (H3K27ac, H3K4me3, and H3K4me1)
and DNase I accessibility analysis. Ligand-activated GR
binds to several thousand genomic loci [5, 7, 8, 41], of
which more than 90 % (7679/8303) were located dis-
tally (>5 kb) from transcription start sites in HeLa
cells (Additional file 1: Figure S1A). The vast majority
(6760/7679) of these DBSs were DNase I accessible,
bound by P300, and marked with H3K27ac and
H3K4me1 prior to hormone stimulation (Fig. 1a–c).
We refer to these as “pre-existing” P300 sites. Import-
antly, a subset of GR DBSs (919/7679) displayed the
hallmarks of poised enhancers prior to ligand treat-
ment, being largely inaccessible to DNase I, lowly
marked with H3K4me1, and not marked with H3K27ac
and P300. Interestingly, P300 was robustly recruited to
these epigenetically dormant loci upon GR induction
(“induced” P300 sites; Fig. 1a–c). At a smaller subset
(529/6760) of GR DBSs, P300 occupancy was moderately
reduced upon hormone treatment (data not shown). Next,
we analyzed the pre-existing and induced P300 DBSs for
TF motifs [7]. As expected, ligand-induced P300 DBS
were highly enriched for glucocorticoid response elements
(GREs), whereas AP1 was the most prevalent motif de-
tected at pre-existing P300 sites (Fig. 1d). Our observa-
tions together with published data [5] suggest that at the
induced P300 DBSs that are pre-marked with H3K4me1,
GR binds directly to consensus GREs and recruits P300 to
set up enhancer-like elements.
P65 was also predominantly bound at distal gen-
omic loci (11,454/12,546) (Additional file 2: Figure S2A),
of which the majority (10,453/11,454) were occupied by
P300 prior to TNFα stimulation (pre-existing P300 sites).
At a subset of p65 DBSs (1001/11,454), P300 was de-
tectable only upon TNFα stimulation (Additional file 2:
Figure S2B,C). TNFα-induced P300 DBSs were enriched
for the NFκB response element (NFκB-RE) (Additional
file 2: Figure S2D). Furthermore, induced P300 DBSs
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Fig. 1 (See legend on next page.)
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that were barely or not marked by H3K27ac were in-
accessible to DNase I, yet displayed readily detectable
levels of H3K4me1 prior to TNFα induction and p65
binding (Additional file 2: Figure S2E). In line with a
recent study in mouse macrophages [34], we presume
that TNFα induction activates poised or latent en-
hancers. We also observed pre-existing P300 binding at
many sites (~25,000) that were not significantly co-
occupied by GR or p65 (Additional file 3: Figure S3A,B).
These sites likely have a regulatory role in association with
other TFs.
Because GR and p65 share a large number of regula-
tory elements (~30 %) and co-regulate many genes, we
performed a similar analysis upon co-activation of GR
and p65. We detected all the induced P300 DBSs that
were uncovered upon single activation of GR or p65. An
additional subset of inducible P300 sites (~700) was un-
veiled only upon co-stimulation, displaying significantly
increased DNase I accessibility and H3K27ac, and a mar-
ginal increase in H3K4me1 (Additional file 4: Figure S4,
Additional file 5: Figure S5, Additional file 6).
Taken together, GR and p65 mostly join pre-existing
enhancer-like P300 DBSs that are set up by other TFs
such as AP1. At a subset of latent genomic locations
marked with low levels of H3K4me1, GR and/or NFκB
binding induces DNA accessibility, recruitment of P300,
and H3K27ac deposition. Because the induced P300 sites
are highly enriched for their respective consensus re-
sponse elements, it appears that recruitment of GR and
NFκB to their respective cis-acting elements can initiate
the formation of an active enhancer configuration, in
line with recent studies [5, 33, 34].
ChIA-PET reveals P300 enhancer interaction networks
Next we focused on long-range chromatin contacts
associated with P300 DBSs. We performed chromatin
interaction analyses on co-stimulated cells to uncover
the largest number of induced P300 DBSs (2881), and
contrasted them to vehicle treatment. We performed
ChIA-PET, an antibody-based method, to map the
genome-wide chromatin interactions at high resolution
[35, 36, 42]. We mapped the chromatin interactions
using P300 and POLII antibodies. Sequencing of the
P300 ChIA-PET libraries yielded 36.7 and 18.2 million
uniquely mapped paired-end tags (PETs) for vehicle and
co-stimulated samples, respectively. Among these, 1.4
and 1.2 million reads were self-ligation PETs (defined as
ligation endpoints or anchors less than 5 kb apart) ac-
counting for 15,148 and 16,366 putative P300 binding
sites in vehicle and co-treated libraries, respectively
(Additional file 7: Table S1). The vast majority (>90 %)
of these self-ligation PETs co-localized with the P300
binding sites identified by ChIP-seq (Additional file 8:
Figure S6A). ChIP-seq binding sites with low signal
strength were not detected as binding sites in ChIA-PET
data sets (Additional file 8: Figure S6B). Therefore, we
used ChIP-seq binding sites (identified from ~20 million
unique reads) as anchors to identify high confidence
chromatin contacts. Ligation PETs that had their an-
chors between 5 and 1000 kb from each other and co-
localized with high confidence P300 ChIP-seq binding
sites were defined as long-range interactions. We identi-
fied 2363 and 5429 intra-chromosomal interactions
using the P300 antibody in vehicle and co-stimulated
cells, respectively. Using a similar approach, a large
number of intra-chromosomal interactions were de-
tected in a ChIA-PET analysis using a POLII antibody
(Additional file 9: Table S2). P300 and POLII ChIP-seq
binding sites that were involved in chromatin interac-
tions were of higher signal strength compared to those
not detected in chromatin interactions (Additional file 8:
Figure S6C).
The majority of P300-associated long-range interac-
tions occurred between distal regulatory elements
(DBSs, ~60 %), whereas about 20 % occurred between
promoters and DBSs (Fig. 2a). In contrast to the
P300 interactome, POLII-associated interactions were
found predominantly between promoters (64 %) and
only 19 % involved DBS-promoter interactions (Fig. 2b).
Visual inspection suggested that identified chromatin in-
teractions occurred frequently between a multitude of
P300 DBSs that aggregate into interaction subdomains
(Additional file 8: Figure S6D) similar to replication or
TADs [43, 44]. Indeed, more than 95 % of all P300 and
POLII long-range interactions were confined to such do-
mains as defined by DNA replication timing in HeLaS3
cells [44, 45] (Additional file 8: Figure S6E). Whereas the
average TAD length is ~1.7 Mb, the average widths of
P300 and POLII subdomains were 118 kb and 96 kb, re-
spectively. Direct comparison of individual P300 and
POLII interaction domains revealed that two fifths
(39.6 %) overlapped, whereas the remainder appeared
to involve only P300 or POLII (Fig. 2c, upper panel).
The degree of P300 and POLII anchor overlap in
(See figure on previous page.)
Fig. 1 Activated glucocorticoid receptor (GR) recruits P300 to epigenomically latent genomic regions. a Color profile depicting the GR and P300
signal at all GR-bound regions with either constitutive or ligand (triamcinolone acetonide [TA]) -induced P300 occupancy. b Example screenshot
depicting the TA-induced P300 distal binding site (DBS; dotted box) and constitutive P300 DBS. c Basal (untreated cells) H3K27ac, DNase I hyper-
sensitive site, and H3K4me1 signal at all GR-induced and constitutive P300 DBSs. d Motif occurrence at all GR-bound DBSs presented as a function
of TA-dependent P300 recruitment (x-axis). DMSO dimethyl sulfoxide, RE response elements
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Fig. 2 P300 ChIA-PET interaction profile shows an enhancer-centered interaction pattern in contrast to promoter-centered RNA polymerase II
(POLII) interactome. a Proportion of distal binding site (DBS)-promoter, promoter-promoter, and DBS-DBS interactions identified by P300 ChIA-PET
in cells treated by vehicle (dimethyl sulfoxide [DMSO]) (upper panel) or triamcinolone acetonide (TA) + tumor necrosis factor alpha (TNFα) (lower
panel). b Proportion of DBS-promoter, promoter–promoter, and DBS–DBS interactions identified by POLII ChIA-PET in cells treated with vehicle
(upper panel) or TA + TNFα (lower panel). c Venn diagram depicting the extent of overlap between P300 interaction subdomains and POLII interaction
subdomains (upper panel). Histogram depicting the percentage of P300 and POLII shared anchors in P300 & POLII interaction subdomains (lower panel).
d Example screenshots of P300-rich (left panel), P300 & POLII-rich (middle panel), and POLII-rich (right panel) interaction subdomains depicting the
ChIP-seq and ChIA-PET interaction data. e Distribution of glucocorticoid receptor (GR) (left panel) and p65 (right panel) binding sites in P300 rich, P300
& POLII-rich, and POLII-rich interaction subdomains
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P300 and POLII shared interaction domains varied,
with most of the subdomains sharing less than 50 %
of anchors (Fig. 2c, lower panel). Representative ex-
amples of P300-rich, P300 and POLII, and POLII-rich
interaction subdomains are shown in Fig. 2d.
Because GR and p65 preponderantly bind to putative
enhancers that are marked with P300, it would be ex-
pected for GR and p65 binding sites to be enriched
within the P300 ChIA-PET interaction network. Indeed,
about 60 % of GR and 50 % of p65 binding sites were lo-
cated within P300 centric interaction subdomains (P300
rich, P300 & POLII). POLII-rich promoter–promoter
networks were largely devoid of GR and p65 binding
events (Fig. 2d,e).
Ligand treatment enhances long-range interactions at
induced P300 distal binding sites
Next we set out to investigate whether pre-existing and
induced P300 sites participate equally in long-range
chromatin interactions. Upon ligand activation we ob-
served a significant gain of DNaseI accessibility and ac-
tive chromatin marks at induced P300 DBSs. We reason
that these sites might have an increased interaction upon
ligand activation.
To validate the P300-mediated long-range interactions
and to gain insight into their frequency, we selected 4C
viewpoints in eight different P300 interaction subdo-
mains that encompassed 58 different genomic loci (an-
chors) in our ChIA-PET analysis. 4C-seq libraries from
at least two independent biological replicas per view-
point were sequenced to obtain more than 2 million
high-quality, uniquely aligned reads (Fig. 3, Additional
file 10: Figure S7, Additional file 11: Figure S8, Additional
file 12: Figure S9). This sequencing depth is regarded
adequate to map all ligation events within the view-
point [46].
In the ZBTB16/NNMT locus (Fig. 3a), transcription of
the NNMT gene was induced by co-stimulation. This
locus contained one ligand-induced P300 binding site
that also gained H3K27ac and DNase I accessibility (see
also Fig. 1b) and three pre-existing P300 sites. Using one
of the pre-existing P300 sites as the viewpoint in 4C
experiments, we detected its interaction with other pre-
existing P300 sites. Upon ligand activation, we observed
the formation of novel interactions involving the ligand-
induced P300 DBS as well as a general increase in the
interaction signal at pre-existing sites. In ChIA-PET, we
detected interactions between all the enhancers only
upon ligand induction.
The KLF6 locus encompassed multiple constitutive
and four induced P300 binding sites (Fig. 3b). Upon
stimulation, transcription of the KLF6 gene was highly
induced and multiple enhancers gained P300, H3K27ac,
and DNase I accessibility. A GR-induced DBS was used
as the viewpoint for 4C. In vehicle-treated cells, we
detected weak 4C signals between the bait and sur-
rounding pre-existing and induced P300 DBSs. These
contacts were robustly increased upon co-stimulation.
An additional six genomic viewpoints showed a simi-
lar increase in interaction frequencies and inclusion
of induced P300 binding sites in the interaction net-
work upon ligand induction (Additional file 11: Figure S8,
Additional file 12: Figure S9).
To assess the interaction frequency at P300 DBSs, we
divided the P300 DBSs that were detected in our 4C
analysis (eight viewpoints) into induced and pre-existing.
For each group we plotted the average of P300 ChIP-seq
and 4C signal (reads per kilobase per million mapped
reads [RPKM]) in control and stimulated cells. The con-
stitutive P300 binding sites displayed a similar ChIP-seq
and 4C signal pattern in vehicle-treated and ligand-
treated cells (Fig. 3c). Importantly, induced P300 binding
sites showed a significantly higher (p < 0.001, t-test) 4C
signal in ligand-treated cells than the control cells
(Fig. 3d).
GR and NFκB activation enhances long-range chromatin
contacts
The 4C assays support the presence of long-range inter-
action networks among P300 DBSs. Furthermore, they
uncovered a significant increase in contact frequency at
induced but not at pre-existing P300 DBSs (Fig. 3c,d).
To further investigate this difference, we divided the
ChIA-PET interaction subdomains into two groups: sub-
domains containing only pre-existing P300 DBSs, and
subdomains containing at least one induced P300 DBS.
We then compared their interactome in the ChIA-PET
profiles. However, to directly compare the two condi-
tions, the immunoprecipitation-introduced bias inherent
to ChIA-PET had to be taken into account. The ChIP
step results in a restricted representation of the interac-
tome. A possible confounding factor in ChIA-PET is
that chromatin regions with a higher number of binding
sites with high occupancy (RPKM) – that is higher local
concentration of P300 – may be ChIPed with higher effi-
ciency than regions with fewer binding sites and lower
P300 occupancy.
In order to accurately compare the pre-existing and
induced subdomains in untreated and co-stimulated
ChIA-PET libraries, we first estimated the local P300
concentrations (average P300 signal) by summing up the
RPKM values of P300 DBSs in ChIA-PET interaction
subdomains harboring at least five P300 DBSs with a
different degree of P300 induction (Fig. 4a). With few
exceptions, the co-stimulation marginally affected the
local concentration of P300 as compared to vehicle-
treated cells (<2-fold) (Fig. 4b). Next, we selected subdo-
mains that upon co-stimulation responded with no more
Kuznetsova et al. Genome Biology  (2015) 16:264 Page 6 of 15
than a 25 % change in total P300 concentration (subdo-
mains within the shaded area in Fig. 4b). We computed
the chromatin interaction frequencies (ChIA-PET inter-
actions/subdomain) in subdomains that had at least one
or no induced P300 DBSs. In order to take into account
the coverage difference of the two P300 ChIA-PET librar-
ies, we used the one-sided Mann–Whitney–Wilcoxon test.
Interestingly, P300 hubs bearing induced P300 DBSs dis-
played a significant increase in chromatin contacts upon
co-stimulation versus vehicle-treated cells (Fig. 4c, upper
panel). Such preference is not evident in subdomains har-
boring only pre-existing P300 DBSs (Fig. 4c, lower panel).
Thus, preferential involvement of ligand-induced P300
DBSs in chromatin interactions implies that GR and/or
A
C D
B
Fig. 3 Glucocorticoid receptor (GR)-dependent and p65 activation-dependent changes in chromatin interactions. a, b Direct comparison of
chromatin contacts revealed by P300 ChIA-PET and 4C-seq analyses at the ZBTB16 (a) and KLF6 loci (b). 4C-seq bait loci are marked on each
screenshot (blue arrow). Genomic regions that show a marked change in 4C signal upon triamcinolone acetonide (TA) + tumor necrosis factor
alpha (TNFα) treatment are marked red below the Δ4C track. c Direct comparison of changes in average ChIP-seq signal (left panel) and 4C signal
(right panel) at all the constitutive P300 distal binding sites (DBSs) within the ten 4C-seq genomic view points upon TA + TNFα treatment. d Direct
comparison of changes in average ChIP-seq signal (left panel) and 4C signal (right panel) at all the induced P300 DBSs within the ten 4C-seq
genomic view points upon TA + TNFα treatment. DMSO dimethyl sulfoxide
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NFκB binding to DNA via their cognate cis-acting ele-
ments opens up the closed chromatin by recruiting
chromatin-remodeling complexes. Such open chromatin
regions preferentially contact other P300 DBSs with a
similar regulatory factor composition and chromatin
state, resulting in an interaction network that is synchro-
nized upon ligand-dependent GR and/or NFκB recruit-
ment, resulting in increased contact frequency. We
preferentially detected the networks that were highly af-
fected by ligand stimulation. These networks are already
established prior to stimulation (as detected by 4C-seq).
However, the increase of the contact frequency at in-
duced P300 DBSs upon ligand activation indicates the
synchronization of such networks.
We therefore consider that the (over) representation
of induced interactions in our data sets may imply that a
considerably larger proportion of cells in the population
have the P300 protein network at these loci because the
queried loci were synchronized by ligand treatment.
GR and NFκB networks are enriched with their target
genes
Finally, we assessed the impact of agonist-induced regu-
latory elements and their special re-organization on
transcriptional regulation using gene-body POLII density
as a direct read-out [6]. We quantified all the DBS-
promoter contacts that were identified in both P300 and
POLII interaction data sets. Importantly, 70 % of P300
and 50 % of POLII bound DBS were not contacting the
nearest (first) active transcription start site (TSS) but a
more distal TSS (Fig. 4d). Next, we computed the gene-
body POLII density of genes that were connected to (in-
duced and pre-existing) P300 DBSs. We observed a con-
sistent positive correlation between ligand-dependent
gene induction and P300 induction at the DBS (Fig. 4e).
Genes linked to induced P300 DBSs respond avidly to
ligand induction as compared to genes that are interact-
ing with pre-existing P300 DBSs. Similarly, expression of
all genes in the agonist-induced interaction subdomains
was significantly increased upon co-stimulation whereas
genes in the constitutive subdomains were unresponsive
to agonists (Fig. 4f ). Gene ontology (GO) analysis of
genes in the induced P300 hubs instigated by activation
of NFκB (TNFα or co-stimulated) are enriched for GO
terms associated with inflammatory response whereas
genes linked to activated GR-induced P300 hubs are
enriched for various biological processes, including
macromolecule metabolic processes. Genes connected to
constitutive P300 hubs are enriched for GO terms asso-
ciated with general cellular processes (Additional file 13:
Table S3). Taken together, our data strongly suggests
that GRE-containing or NFκB RE-containing latent en-
hancers that are activated upon ligand stimulation pref-
erentially engage the GR and NFκB target genes and
subsequently modulate their expression.
Discussion
In this study, we have analyzed the impact of agonist-
activated GR and p65 (NFκB) on chromatin state, 3D
organization, and transcriptional regulation. Activated
GR and p65 are mainly recruited to pre-existing regula-
tory elements that are pre-bound by P300, and display
the epigenetic signature of active enhancers prior to TF
activation, that is, they fall into the “permissive” model
category. Our findings are in line with recent findings
suggesting that signal-dependent TFs largely access the
enhancer landscape that is set up by other lineage-
specific TFs such as PU.1, C/EBPα, and AP1 [4, 5, 30, 34].
However, in ChIP-seq, we also observed de novo re-
cruitment of P300 by activated GR and/or p65 to
thousands of regions that subsequently acquired
enhancer-like epigenetic features, in line with recent
studies [5, 33, 34]. ChIA-PET and 4C analysis indicate
that these sites are involved in interaction that would
fall into the “instructive” category. The chromatin
signature and epigenetic changes in response to ligand
activation at these induced DBSs are reminiscent of
“latent enhancers” [34, 47].
(See figure on previous page.)
Fig. 4 Ligand-induced enhancement of chromatin contacts within P300 interaction subdomains. a Bar plot depicting the percentage of induced
P300 peaks in the P300 hubs with at least five P300 peaks. b P300 local concentration at all P300 interaction subdomains that are ordered based
on average P300 density (x-axis) and ligand-induced change in P300 concentration (y-axis). Sub-domains harboring at least five P300 distal bind-
ing sites (DBS) are presented. c Total number of chromatin interactions detected at each interaction subdomain upon vehicle dimethyl sulfoxide
(DMSO, blue dots) and triamcinolone acetonide (TA) + tumor necrosis factor alpha (TNFα, red dots) treatment is presented. Sub-domains that show
no more than 25 % change in total P300 concentration (reads per kilobase per million mapped reads) that either harbor at least one induced
P300 DBS (upper panel) and only constitutive P300 DBS (lower panel) are used. p-values (Mann–Whitney) were generated by comparing interaction
ratios (TA + TNFα/DMSO) between the induced and constitutive subdomains that are within each bin (shaded area). d Proportion of DBSs to
nearest first gene promoters or DBSs to distal gene promoter interactions identified by P300 and RNA polymerase II (POLII) ChIA-PET analysis. TSS
transcription start site. e Co-activation-dependent changes in expression of genes that are directly looped to P300 DBSs. P300 DBSs were initially
ordered according to agonist-induced P300 recruitment (low to high) and subsequently divided into 10 equal bins. The average transcriptional
change of genes in each bin is presented. Expression of genes that are in bins harboring significantly repressed (gray), induced (red), and
constitutive (blue) P300 DBSs upon co-stimulation. f Co-activation-induced changes in expression of genes that are within interaction
subdomains harboring either induced or only constitutive P300 DBSs
Kuznetsova et al. Genome Biology  (2015) 16:264 Page 9 of 15
An important question is how the agonist-induced en-
hancers and their target genes are spatially organized.
We have compared the P300-mediated chromatin inter-
actomes before and after GR and NFκB co-activation.
Using ChIA-PET against P300, we observed the forma-
tion of P300-mediated long-range interactions at subdo-
mains bearing induced P300 DBSs in response to ligand
activation. With the current depth of ChIA-PET librar-
ies, these interactions appeared to be either formed de
novo (from latent enhancers) or stabilized upon ligand
induction. In 4C analysis we reproducibly detected in-
creased interactions at induced P300 DBSs; the induc-
tion in the 4C approach is, however, less pronounced as
compared to ChIA-PET. This difference is likely due to
intrinsic differences between the two assays: 4C detects
long-range interactions irrespective of the presence or
absence of P300 and hence is able to detect lower
strength or lower frequency interactions and those that
are P300 independent. In ChIA-PET, the immunoprecip-
itation step enriches for interactions mediated by P300
and does not pick up P300 independent interactions,
providing an all or nothing picture. Collectively and in
agreement with each other, our ChIA-PET and 4C re-
sults show that activation of GR and/or NFκB facilitates
an induced interaction signal at a subset of DBSs. We
interpret this increased signal as an increase in either
the interaction frequency (stabilization of a network) or
in the proportion of cells that engage in such interaction
(synchronization of a network).
Recent 3C-based studies of individual loci reported on
the role of GR and NFκB in long-range gene regulation
[10, 13, 48]. For example, the Lcn2 gene locus is engaged
in multiple long-range contacts with GR DBS. In agree-
ment with our findings, it was shown that activated GR
increases local chromatin interactions without dramatic
change in 3D organization. In another report exploiting
the 4C approach, activated GR was shown to bind a
downstream enhancer of the Tsc22d3 gene, causing a
2-fold increase in long-range enhancer–promoter inter-
action and activation of transcription [13]. Similarly, TNFα
induces chromatin interactions between distal NFκB-
bound enhancers and the promoter proximal regulatory
sites of CCL2 [10]. In contrast, a recent study based on
genome wide Hi-C analysis revealed that the vast majority
of TNFα responsive enhancers, as determined by p65
binding, show little change in DNA looping after TNFα
treatment [16]. The authors note that only ~15 % of p65
DBSs display an activated enhancer signature (increase in
H3K27ac signal and enhancer RNA production) upon
TNFα treatment. The apparent discrepancy with our
study is likely due to the differences in resolution of ap-
plied techniques. In agreement with Jin et al., we found
that the majority of long-range interactions are pre-
established and not dynamic; however, by applying
ChIA-PET and high-resolution 4C, we found a signifi-
cant increase in long-range interactions at induced
but not constitutive P300 DBSs. These changes in a
subset of interactions are conceivably difficult to pick up
using a relatively low-resolution Hi-C-only approach.
One of the questions debated in the field of chromatin
topology is the extent to which long-range interactions
are dynamic and correlate with gene expression, such as
in response to extracellular stimuli or during differenti-
ation. The instructive model suggests de novo formation
of long-range interactions, where lineage-specific and/or
signal-induced TFs establish a new interaction landscape
and affect the expression of their target genes [10–14, 49].
Our data provides support for this model: at ligand-
induced DBSs, ChIA-PET and 4C data show an increased
interaction signal at loci that were largely closed with low
or no active epigenetic marking (H3K27ac) but with low
levels of H3K4me1, reminiscent of latent enhancers [34].
Our data also provide support for the permissive model,
showing that the long-range interaction landscape is
pre-formed in the absence of ligand induction.
Ligand-activated TFs appear to join a pre-set network
of enhancers and trigger transcription by lineage-
specific and/or signal-induced TFs [16–18].
Conclusions
We conclude that the ligand-activated GR and p65
induce chromatin accessibility, P300 recruitment, and
alterations of 3D chromatin structure at a subset of gen-
omic loci. At subdomains with induced P300 binding,
activated GR and p65 facilitate close spatial proximity of
the induced P300 DBS with a pre-existing interaction
network and enhancement of 3D chromatin contacts. Our
data suggest that ligand induction causes synchronization
or stabilization of active chromatin states and higher order
structure in a large proportion of cells to facilitate efficient
regulation of their target genes. We speculate that this
spatial clustering of regulatory elements can cause an in-
crease in the local concentration of regulatory proteins,
which ultimately can enhance the transcriptional activity
of associated genes. Further experiments are needed to
validate and expand on these findings, to elucidate the role
of inducible TFs in long-range regulation, and to firmly es-
tablish that increased physical looping interaction indeed
leads to increased transcription.
Methods
Cell culture
HeLa B2 cells were maintained as described [7]. Cells
were cultured in Dulbecco’s Modified Eagle Medium
supplemented with 10 % charcoal stripped fetal calf
serum for 72–96 h before subsequent treatment and/or
harvesting. Cells were treated with either DMSO or 1 μM
of TA (T6501, Sigma-Aldrich, St. Louis, Missouri, United
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States) for 4 h with or without an additional treatment with
10 ng/mLTNFα (T0157, Sigma-Aldrich) for the last hour.
ChIP-seq
ChIP was performed according to standard protocol [50]
with minor modifications. Paraformaldehyde (1 %)
cross-linking was carried out for 10 min followed by the
chromatin preparation as described earlier [7]. Nuclei
were re-suspended in ChIP-incubation buffer at a con-
centration of 20 × 106 cells/mL and sheared (seven cycles
with each cycle containing 10 s power on and 10 s
interval) using Bioruptor®Plus (B01020001, Diagenode,
Liege, Belgium). Sonicated chromatin equivalent of 4 ×
106 cells was incubated with relevant antibody overnight
at 4 °C. Antibodies against P300 (sc-585x, Santa Cruz
Biotechnology, Inc., Dallas, Texas, United States), POLII
(MMS-126R-500, Covance, Inc., Princeton, New Jersey,
United States), H3K27ac (C15410196, Diagenode),
H3K4me1 (C15410194, Diagenode), and H3K4me3
(C15410003, Diagenode) were used. ChIP-seq sample
preparation and sequencing was performed according to
manufacturer’s instructions (Illumina, San Diego, Cali-
fornia, United States) and essentially as described [6, 9,
51] (http://www.blueprint-epigenome.eu).
ChIP-seq data analysis
The image files generated by HiSeq2000 (Illumina) were
processed to extract sequence data and the 36/42 bp
tags were unambiguously mapped to the human genome
(NCBI, hg19) using the bwa aligner, allowing at most
one nucleotide mismatch. Reads were further direction-
ally extended to 200 bp, corresponding to the original
length of the DNA fragments used for sequencing. For
each base pair in the genome, the number of overlapping
sequence reads was determined, averaged over a 10 bp
window, and visualized in the University of California
Santa Cruz genome browser (http://genome-euro.ucsc.edu).
ChIP-seq data sets were normalized as described [6, 7] in
order to eliminate the differences caused by sequencing
depth/mapping efficiency.
Detection of putative P300 and POLII binding sites was
performed using MACS (version 1.4.2) [52] with the
p-value <10−9. Peaks identified by using each antibody in
DMSO, TA, TNFα, and TA +TNFα were combined in a
common pool and sequence tags were counted under each
peak location (for each data set separately). Then we calcu-
lated the intensity (log2 RPKM) of peaks in each treatment.
Binding sites that showed a significant change (median ±
2 ×median absolute deviation; p < 0.05) in signal for P300
or POLII in a treatment compared to that in the vehicle-
treated sample were regarded as dynamic binding sites.
Published GR, p65, and POLII ChIP-seq data that were
generated in an identical experimental setup in HeLa B2
cells [GEO: GSE24518] were used in this study.
DNase I-seq
DNase I libraries were prepared from DMSO-treated
and TA + TNFα-treated Hela B2 cells as described
(http://www.uwencode.org/protocols). In brief, 5 × 106
nuclei were isolated using Buffer A (15 mM NaCl; 60
mM KCl; 1 mM EDTA, pH 8.0; 0.5 mM EGTA, pH 8.0;
15 mM Tris–HCl, pH 8.0; 0.5 mM spermidine) supple-
mented with 0.06 % IGEPAL CA-630 detergent. DNase I
treatment (60 units) was performed for 3 min and the
reaction stopped with stop buffer (50 mM Tris–HCl, pH
8; 100 mM NaCl; 0.10 % SDS; 100 mM EDTA, pH 8.0; 1
mM spermidine; 0.3 mM spermine). The sample was
further fractionated on 9 % sucrose gradient for 24 h at
25,000 rpm at 16 °C. Fractions containing DNA frag-
ments smaller than 1 kb were purified and processed for
sequencing according to the Illumina library preparation
protocol. Normalized (read number equalized) DNase I
data sets were used for the downstream analysis and
visualization.
ChIA-PET library preparation
ChIA-PET libraries were prepared using the standard
protocol [35, 36]. Chromatin preparation and ChIP en-
richment using P300 and POLII antibodies were per-
formed as described above. Briefly, chromatin captured
on magnetic beads was trimmed (blunt end), phosphory-
lated on 5′ ends, then underwent biotinylated half-linker
ligation. Chromatin complexes were then divided into
two equal halves and two independent half-linker
ligation reactions were performed using half-linkers A
and B containing specific barcodes (linker-A TAAG;
linker-B ATGT). Subsequently, chromatin complexes
were eluted from the beads and two linker ligation ali-
quots were combined together for proximity ligation
under diluted conditions. Subsequently, reverse cross-
linked and purified circular DNA was digested using
MmeI enzyme (the restriction site is encoded on the
linker). Next, biotinylated DNA fragments were immobi-
lized on M-280 streptavidin Dynabeads (Invitro-
gen, Carlsbad, California, United States) followed by
adaptor ligation. The efficiency of the library preparation
was evaluated by polymerase chain reaction (PCR) and
subsequent gel electrophoresis. Next, each library char-
acterized by adaptor-ligated DNA fragments carrying 20
bp of genomic DNA flanking the 36-bp linker sequence
on either side was sequenced on a HISeq200 (Illumina).
A typical sequencing run yielding 200 million single-end
reads of 100-bp length was generated for each library.
ChIA-PET data analysis
The first 72 bp of each sequenced read carrying the
complete ChIA-PET ligation product (linker plus gen-
omic DNA) was taken for the further analysis after trim-
ming the ends of each read. Subsequently, single-end
Kuznetsova et al. Genome Biology  (2015) 16:264 Page 11 of 15
sequenced reads were split at the linker ligation junction
(linkerA/B-|-linkerA/B) and flipped to make the data
compatible (similar to paired-end sequencing reads) for
the ChIA-PET data analysis pipeline [42]. The average
distance between binding sites (P300 and POLII), identi-
fied based on the ChIA-PET self-ligation PETs and the
binding sites identified by ChIP-seq, were examined to
ascertain the reproducibility of binding sites by these
methods. The binding sites identified by both methods
were highly comparable, but a larger number of total
binding sites were identified by ChIP-seq owing to the
higher sequencing depth. Therefore, we used ChIP-seq
binding sites as anchors to identify the intra-chromosomal
and inter-chromosomal interaction PETs. True long-range
interaction signals were distinguished from the non-
specific technical interaction noise by using the method
described earlier [42]. Briefly, interaction PETs having a
PET count equal to two or more for P300 libraries and
three or more for POLII libraries at a false discovery rate
<0.05 were considered as high confidence interaction clus-
ters. We used a 5 kb and 1 Mb genomic span as the lower
and upper cutoff limits, respectively, to define the high
confidence interaction PET data. Each interaction PET
contained a pair of interacting anchors. Direct overlap
(book end or 1 bp) of anchors of each cluster with that of
other clusters was performed to identify interaction com-
plexes or interaction subdomains. Hence, the interaction
clusters were further collapsed in to interaction com-
plexes/subdomains based on the interconnectivity of the
PET clusters.
Identification of dynamic interactions using ChIA-PET
data sets
To minimize the bias induced by local P300 concentra-
tion on the chromatin interactions detected by ChIA-
PET, we analyzed the changes of interaction frequencies
per each P300 ChIA-PET defined subdomain as follows.
For each subdomain, we counted the number of P300
peaks and calculated the P300 concentration (average
log2 RPKM) in DMSO-treated and TA + TNFα-treated
samples. All the subdomains are ranked by the average
P300 concentration of DMSO and TA + TNFα treat-
ments. We discarded the subdomains with less than five
P300 peaks, and separated subdomains with at least one
induced P300 peak (261 subdomains) and the ones with
only constitutive P300 peaks (283 subdomains). We plot-
ted the number of interaction clusters identified in DMSO
and TA +TNFα data sets separately for individual subdo-
mains. The subdomains were further filtered by the fold
change of P300 concentration (>−0.3 and <0.3) and this
resulted in 131 and 206 subdomains, respectively. The
Mann–Whitney test was adopted to investigate the
agonist-induced change in average chromatin interaction
frequencies in comparable groups of subdomains that
harbor only constitutive P300 DBSs against those having
at least one agonist-induced P300 DBS.
4C-seq library preparations
4C assays were performed as described previously [46]
with minor modifications. Briefly, 107 cells were cross-
linked for 10 min with 2 % paraformaldehyde, quenched
with glycine, and lysed in 50 mL lysis buffer (50 mM
Tris, pH 7.5; 150 mM NaCl; 5 mM EDTA; 0.5 % NP-40;
1 % TX-100; 1X protease inhibitors) for 30 min. Nuclei
were then digested by DpnII enzyme followed by inacti-
vation of the restriction enzyme by incubating at 65 °C
for 20 min. The digested chromatin was subsequently
ligated (circularized) overnight at 16 °C with 50 U T4
ligase. Ligated chromatin was then reverse cross-linked
by incubating with proteinase K at 65 °C and the RNA
was removed by additional incubation at 37 °C with RNase
A. The purified DNA was further digested with a second
restriction enzyme of choice (BfaI, MseI, or NlaIII)
followed by circularization of the DNA. The 4C product
was subsequently amplified with bait-specific inverse
primers (Additional file 14: Table S4). From each 4C
library, about 3200 or 800 ng DNA was amplified in
multiple parallel PCR reactions containing 200 ng of DNA
each, which were subsequently pooled and purified.
Amplified bait-containing DNA fragments were li-
gated to NextFlex DNA barcoded adaptors (Bioo Scien-
tific, Austin, Texas, United States). Adaptor-ligated DNA
was purified by Agencourt AMPure XP purification system
(Beckman Coulter, Brea, California, United States), PCR
amplified (eight cycles), and sequenced single-end on the
Illumina HiSeq2000 to obtain 50-bp-long reads.
4C-seq data analysis
To improve the mappability of the sequence reads, we
generated a reduced genome by extracting the sequences
flanking the DpnII sites (30 bp on each strand from the
DpnII sites to downstream) based on build version hg19
of the human genome. Then we estimated the mappabil-
ity of the extracted sequences (each strand separately)
and only uniquely mappable DpnII sites were considered
for downstream analysis.
All the reads from each library were parsed based on
the bait-specific primer sequence and mapped to the re-
duced genome using bwa (version 0.6.2) with the default
parameters. The mapping data of the individual libraries
are summarized (Additional file 15: Table S5). We ini-
tially mapped each replicate library separately and
merged the replicate libraries based on their quality. The
4C signal was calculated using a sliding window of 10 kb
(±5 kb of a given DpnII site) and normalized to the total
number uniquely mapped reads. Δ4C is the difference of
4C signal in each genomic bin (10 kb) between the nor-
malized DMSO and TA + TNFα data sets.
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Gene ontology analysis
GO analysis was performed using the DAVID web tool
[53, 54]. Gene sets were analyzed for enriched GO terms
(biological processes) compared to the human genome
database as background. Fisher’s exact test was used to
identify significantly enriched GO terms.
Data availability
All the ChIP-seq, ChIA-PET, and 4C raw data files have
been submitted to GEO database [GEO: GSE61911].
Previously published GR, p65, and POLII ChIP-seq data
can be accessed via [GEO: GSE24518].
Ethical approval
No approvals were required for the study, which com-
plied with all relevant regulations.
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Additional file 1: Figure S1. GR binds predominantly to distal binding
sites. Pile-up heat map depicting the H3K4me1 and H3K4me3 signal
around (±12 kb) all GR-bound promoters and DBSs. (PDF 272 kb)
Additional file 2: Figure S2. Activated p65 induces de novo P300
depositions to latent genomic loci. (A) Pile-up heat map depicting the
H3K4me1 and H3K4me3 signal around (±12 kb) all p65-bound promoters
and DBSs. (B) Pile-up heat map depicting the p65 and P300 signal at all
p65-bound enhancers upon vehicle, DMSO (−), and TNFα (+) treatment.
(C) Example screenshot depicting TNFα-induced P300 recruitment at
genomic regions (red box) and recruitment of p65 at genomic loci that
are pre-marked by P300. (D) Motif occurrence at all p65-bound DBS
presented as a function of TNFα-dependent P300 recruitment (x-axis)
(top-panel). Level of shared binding of p65 and other TFs at all
p65-bound DBS, presented as a function of TNFα-dependent P300
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Additional file 3: Figure S3. Large numbers of P300-bound loci are
not co-occupied by GR or p65. (A) Average ChIP-seq signal of GR and
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co-stimulation dependent) of inducible P300 DBSs that were identified
upon co-activation of GR and p65. Motif occurrence (%) at all three
clusters of induced P300 DBSs (bar graphs). (B) H3K27ac, DNase I accessibility,
and H3K4me1 signal at all induced P300 DBSs upon vehicle (DMSO) and
co-treatments (TA + TNFα). (C) H3K27ac, DNase I accessibility, and H3K4me1
signal at all constitutive P300 DBSs upon vehicle (DMSO) and co-treatments
(TA + TNFα). (PDF 1137 kb)
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relation to those identified by using ChIA-PET self-ligation PETs. Identical
comparison is performed for both DMSO-treated and TA + TNFα-treated
data sets. (B) P300 ChIP-seq signal at P300 binding sites commonly
identified by ChIP-seq and ChIA-PET and those binding sites that were
uniquely detected in the ChIP-seq data set. (C) P300 ChIP-seq signal at
P300 binding sites that were either involved (anchor) or not involved
(non-anchor) in long-range interaction as identified by ChIA-PET analysis.
(D) An example screenshot depicting the P300 interaction subdomains,
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